EP2900240
CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
20.9.2013:
8.1.2020:
13840379.5
:
19.9.2033
:
CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR
20.9.2013
8.1.2020
:
Merck Sharp & Dohme Corp.:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
:
MAGUIRE, Courtney, K.:
Rahway, New Jersey 07065-0907, US
:
201261705780 P:
26.9.2012:
US
:
US2013060787:
20.9.2013
:
C07D 401/06, A61K 31/4439